FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions for all solid tumour cancers More: US approves Roche's new pan-tumour liquid biopsy test Source: News
read moreNICE says the combination’s cost-effectiveness estimate is higher than what is considered acceptable for NHS use More: Kidney cancer charity slams NICE rejection of Keytruda/Inlyta Source: News
read moreThe studies aim to increase understanding on immune responses to SARS-CoV-2 More: NIHR, UKRI stream £8.4m into coronavirus studies Source: News
read moreFDA pulls J&J’s Invokana boxed warning after reviewing amputation risks—but the sales damage is done chelfand Thu, 08/27/2020 – 12:17 More: FDA pulls J&J's Invokana boxed warning after reviewing amputation risks—but the sales damage is done Source: fierce
read moreFDA balks at recalls for 2 tuberculosis meds despite possible carcinogen contamination kblankenship Thu, 08/27/2020 – 11:11 More: FDA balks at recalls for 2 tuberculosis meds despite possible carcinogen contamination Source: fierce
read morePfizer could score fast COVID-19 vaccine nod, thanks to Hahn’s promise of October FDA review: analyst arlene.weintraub Thu, 08/27/2020 – 10:05 More: Pfizer could score fast COVID-19 vaccine nod, thanks to Hahn's promise of October FDA review: analyst Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals